High and low heparin dose with heparin-coated cardiopulmonary bypass: Activation of complement and granulocytes
- 31 December 1995
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 60 (6) , 1755-1761
- https://doi.org/10.1016/0003-4975(95)00763-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Complement activation during cardiopulmonary bypass: Effects of immobilized heparinThe Annals of Thoracic Surgery, 1994
- Decreased Blood Loss After Cardiopulmonary Bypass using Heparin-Coated Circuit and 50% Reduction of Heparin DoseScandinavian Journal of Thoracic and Cardiovascular Surgery, 1992
- Conventional blood conservation techniques in 500 consecutive coronary artery bypass operationsThe Annals of Thoracic Surgery, 1991
- Analysis of serial measurements in medical research.BMJ, 1990
- Quantification in Enzyme‐Linked Immunosorbent Assay of a C3 Neoepitope Expressed on Activated Human Complement Factor C3Scandinavian Journal of Immunology, 1988
- Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass: A model to estimate human turnover of lactoferrin and myeloperoxidaseEuropean Journal of Haematology, 1987
- Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMolecular Immunology, 1983
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Structural Determinants of the Capacity of Heparin to Inhibit the Formation of the Human Amplification C3 ConvertaseJournal of Clinical Investigation, 1981
- Serum Myeloperoxidase and Lactoferrin in NeutropeniaScandinavian Journal of Haematology, 1977